MELA Sciences enters $12.45M in private placement MELA Sciences announced it has entered into definitive agreements with institutional investors and management for the private placement of $12.45M of the company’s convertible preferred stock, common stock warrants and common stock. The investors in the transaction were funds managed by Sabby Management, which comprise the company’s largest existing beneficial shareholder, and Broadfin Capital. In conjunction with the financing, MELA Sciences’ directors have agreed to purchase $150,000 in restricted common stock priced at 74c per share. MELA intends to use the net proceeds from the offering to re-launch MelaFind.
News For MELA From The Last 14 Days
Check below for free stories on MELA the last two weeks.